← Back to Clinical Trials
Recruiting NCT07727226

NCT07727226 Endoscopists' Perspectives on the Use of Single-Use Gastroscopes in Elective and Subacute Patients in the Endoscopy Unit

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07727226
Status Recruiting
Phase
Sponsor Zealand University Hospital
Condition Upper Gastrointestinal Disorder
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2026-07-27
Primary Completion 2027-10-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Ambu aScope GastroReusable diagnostic gastroscopes (Olympus)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 300 participants in total. It began in 2026-07-27 with a primary completion date of 2027-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this clinical trial is to investigate whether single-use gastroscopes perform comparably to reusable gastroscopes when used in an endoscopy unit during a period of reduced endoscope reprocessing capacity. The main question the study aims to answer is: \- How do endoscopists evaluate the performance of single-use gastroscopes compared with reusable gastroscopes in elective and subacute patients undergoing gastroscopy in the endoscopy unit? Researchers will compare single-use and reusable gastroscopes to determine whether they provide comparable clinical performance. In addition, the study will evaluate the economic consequences of temporarily implementing single-use gastroscopes during a period of reduced reprocessing capacity, as well as compare selected clinical outcomes, including technical success, procedural complications, and the frequency of endoscopic findings. Participants undergoing gastroscopy during the first study period will be examined using a single-use gastroscope. Participants undergoing gastroscopy during the second study period will be examined using a reusable gastroscope.

Eligibility Criteria

Inclusion Criteria: * Elective or subacute gastroscopy in the endoscopy unit * Age ≥ 18 years Exclusion Criteria: * Surveillance gastroscopy for Barrett's esophagus

Contact & Investigator

Central Contact

Camilla Kjelkvist-Born, MD

✉ camkj@regionsjaelland.dk

📞 +4528263875

Principal Investigator

Lasse Bremholm Hansen, PhD,ass.prof

STUDY CHAIR

Surgical department of Zealand University Hospital

Frequently Asked Questions

Who can join the NCT07727226 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Upper Gastrointestinal Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07727226 currently recruiting?

Yes, NCT07727226 is actively recruiting participants. Contact the research team at camkj@regionsjaelland.dk for enrollment information.

Where is the NCT07727226 trial being conducted?

This trial is being conducted at Køge, Denmark.

Who is sponsoring the NCT07727226 clinical trial?

NCT07727226 is sponsored by Zealand University Hospital. The principal investigator is Lasse Bremholm Hansen, PhD,ass.prof at Surgical department of Zealand University Hospital. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology